John Kinnaird Ferguson Maclean

Title: John Kinnaird Ferguson Maclean: Innovator in Pharmaceutical Chemistry

Introduction

John Kinnaird Ferguson Maclean is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of two patents to his name, Maclean's work focuses on developing compounds that address critical medical issues.

Latest Patents

Maclean's latest patents include "Amino-heteroaryl derivatives as HCN blockers." This invention relates to amino-heteroaryl derivatives that possess the general Formula I or a pharmaceutically acceptable salt thereof. These compounds are designed for use in pharmaceutical compositions aimed at treating pain, including neuropathic pain and inflammatory pain. Another significant patent is for "Heterocyclic derivatives," which pertains to a heterocyclic derivative of formula (I). This invention also includes pharmaceutically acceptable salts or solvates and is intended for therapeutic use in treating disorders mediated by glutamate dysfunction, such as schizophrenia and generalized anxiety disorder.

Career Highlights

Throughout his career, Maclean has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme Corporation and Merck Sharp + Dohme B.V. His experience in these organizations has allowed him to contribute to the development of innovative therapeutic solutions.

Collaborations

Maclean has collaborated with notable colleagues, including Simon James Anthony Grove and Angus John Morrison. These partnerships have likely enriched his research and development efforts, leading to impactful inventions in the pharmaceutical sector.

Conclusion

John Kinnaird Ferguson Maclean is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable patents aimed at addressing significant health challenges. His contributions continue to influence the field and improve therapeutic options for patients.